SPECIAL NOTICE
65 -- Therapure TM Reagents
- Notice Date
- 8/20/2024 8:26:43 PM
- Notice Type
- Special Notice
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- NOI-NIAID-24-2229467
- Response Due
- 8/30/2024 1:00:00 PM
- Archive Date
- 09/14/2024
- Point of Contact
- Leah Hinson
- E-Mail Address
-
leah.hinson@nih.gov
(leah.hinson@nih.gov)
- Description
- PRE-SOLICITATION NOTICE Title: TheraPuretm� Reagents �� ID: NOI-NIAID-24-2229467 Post Date:� August 20, 2024 Response Date: August 30, 2024 NAICS: 325414 Introduction This is a Notice of Intent, not a request for proposal.� The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Life Technologies, Carlsbad, California to procure TherapureTM Reagents. The VRC/Vaccine Production Program (VPP) group is responsible for developing a scale able GMP process the items requested need to be standardized with what will be utilized in the VRC�s pilot plant and applicable to a GMP process and analytical standards that are used to characterize and release therapeutic and vaccine candidates to treat diseases including Covid- 19 (SARS2-CoV), HIV, Influenza, Malaria, and Ebola.� Understanding these attributes are �required for moving forward with a candidate to GMP manufacturing and clinical trials. �The VPP is interested in procuring TheraPureTM Biological Reagents �Description of need: �Manufactured by Life Technologies TheraPureTM Pyrophosphatase, Inorganic, Pack Size-0.1, UoM-kU, Concentration-1,UoM Concentration-U/�L, �# of Packs-54 TheraPureTM T7 RNA Polymerase, Pack Size-1000, UoM-kU, Concentration-200, UoM Concentration- U/�L, # of Packs-27 TheraPureTM RNase Inhibitor, Pack Size-50, UoM-kU, Concentration-40, UoM Concentration-U/�L, # of Packs-9 TheraPureTM ATP 100 mM Sodium Solution, Pack Size-5, UoM-ML, Concentration-100, UoM Concentration-mM, �# of Packs-54 TheraPureTM CTP 100 mM Sodium Solution, Pack Size-5, UoM-ML, Concentration-100, UoM Concentration-mM, # of Packs-54 TheraPureTM GTP 100mM Sodium Solution, Pack Size-5, UoM-ML, Concentration-100, UoM Concentration-mM, # of Packs-54 Shipping and Handling FOB Destination, QTY 1 The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.� All responsible sources that could provide comparable services may submit a capability statement that will be considered. If your organization has the potential capacity to support this requirement, please provide the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UEI number and size and type of ownership for the organization; and 2) respondents shall indicate if they are the manufacturer or the distributor of TheraPureTM Reagents. This shall include basic information on product specifications. If an equal product is recommended (not specific to the brand proposed) then sufficient details shall be provided by the respondent describing how the equal product being recommended, meets the minimum specifications of the requirement. Submission Instructions Interested businesses who consider themselves qualified to provide the above-listed items are invited to submit a response to this Notice of Intent by August 30, 2024 at 4:00 PM EST. All responses under this Notice of Intent must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization�s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/b54fa052e5074e798ced72c2ff430687/view)
- Place of Performance
- Address: Gaithersburg, MD 20878, USA
- Zip Code: 20878
- Country: USA
- Zip Code: 20878
- Record
- SN07177381-F 20240822/240820230116 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |